These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7613155)

  • 1. Inhibition of human IgE synthesis in vitro and in SCID-hu mice by an interleukin-4 receptor antagonist.
    Carballido JM; Aversa G; Schols D; Punnonen J; de Vries JE
    Int Arch Allergy Immunol; 1995; 107(1-3):304-7. PubMed ID: 7613155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
    Carballido JM; Schols D; Namikawa R; Zurawski S; Zurawski G; Roncarolo MG; de Vries JE
    J Immunol; 1995 Nov; 155(9):4162-70. PubMed ID: 7594571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors.
    Aversa G; Punnonen J; Cocks BG; de Waal Malefyt R; Vega F; Zurawski SM; Zurawski G; de Vries JE
    J Exp Med; 1993 Dec; 178(6):2213-8. PubMed ID: 7504061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the human IgE response.
    de Vries JE; Yssel H
    Eur Respir J Suppl; 1996 Aug; 22():58s-62s. PubMed ID: 8871045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo.
    Grunewald SM; Werthmann A; Schnarr B; Klein CE; Bröcker EB; Mohrs M; Brombacher F; Sebald W; Duschl A
    J Immunol; 1998 Apr; 160(8):4004-9. PubMed ID: 9558109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).
    König B; Fischer A; König W
    Immunology; 1995 Aug; 85(4):604-10. PubMed ID: 7558156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice.
    Spiegelberg HL; Beck L; Kocher HP; Fanslow WC; Lucas AH
    J Clin Invest; 1994 Feb; 93(2):711-7. PubMed ID: 8113405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny.
    Punnonen J; Cocks BG; de Vries JE
    J Immunol; 1995 Nov; 155(9):4248-54. PubMed ID: 7594582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency.
    Tony HP; Shen BJ; Reusch P; Sebald W
    Eur J Biochem; 1994 Oct; 225(2):659-65. PubMed ID: 7957181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-SCID B cell responses to interleukin-4 and interleukin-13 are mediated by a receptor complex that includes the interleukin-4 receptor alpha chain (p140) but not the gamma c chain.
    Matthews DJ; Hibbert L; Friedrich K; Minty A; Callard RE
    Eur J Immunol; 1997 Jan; 27(1):116-21. PubMed ID: 9022007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain.
    Schnyder B; Lugli S; Feng N; Etter H; Lutz RA; Ryffel B; Sugamura K; Wunderli-Allenspach H; Moser R
    Blood; 1996 May; 87(10):4286-95. PubMed ID: 8639787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
    Maeda S; Yanagihara Y
    Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
    J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CD23 processing correlates with inhibition of IL-4-stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice.
    Mayer RJ; Bolognese BJ; Al-Mahdi N; Cook RM; Flamberg PL; Hansbury MJ; Khandekar S; Appelbaum E; Faller A; Marshall LA
    Clin Exp Allergy; 2000 May; 30(5):719-27. PubMed ID: 10792365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Ig production and isotype switching in severe combined immunodeficient-human mice.
    Vandekerckhove BA; Jones D; Punnonen J; Schols D; Lin HC; Duncan B; Bacchetta R; de Vries JE; Roncarolo MG
    J Immunol; 1993 Jul; 151(1):128-37. PubMed ID: 8326122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant canine IL-13 receptor alpha2-Fc fusion protein inhibits canine allergen-specific-IgE production in vitro by peripheral blood mononuclear cells from allergic dogs.
    Tang L; Boroughs KL; Morales T; Stedman K; Sellins K; Clarke K; McDermott M; Yang S; McCall C
    Vet Immunol Immunopathol; 2001 Nov; 83(1-2):115-22. PubMed ID: 11604166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of IL-13 and its receptor in allergy and inflammatory responses.
    de Vries JE
    J Allergy Clin Immunol; 1998 Aug; 102(2):165-9. PubMed ID: 9723655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 effects on human IgE production in response to IL-4 or IL-13.
    Wood N; Bourque K; Donaldson DD; Collins M; Vercelli D; Goldman SJ; Kasaian MT
    Cell Immunol; 2004; 231(1-2):133-45. PubMed ID: 15919378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction.
    Zurawski SM; Vega F; Huyghe B; Zurawski G
    EMBO J; 1993 Jul; 12(7):2663-70. PubMed ID: 8101483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2 reverses human T cell unresponsiveness induced by thymic epithelium in SCID-hu mice.
    Schols D; Vandekerckhove B; Jones D; Roncarolo MG
    J Immunol; 1994 Mar; 152(5):2198-206. PubMed ID: 8133034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.